Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Angie’s List Inc (ANGI) Joins List of Stocks Ken Griffin is Bullish on During Sell-Off

There is one thing that many great investors have in common: they buy when others are selling. Billionaire Ken Griffin is no exception to the rule, which is why amid a general sell-off, Mr. Griffin made some bullish bets. Recently, Mr. Griffin’s Citadel Investment Group surged its stake in Angie’s List Inc (NASDAQ:ANGI). The investor now owns almost 3.38 million shares of the company, which represent 5.8% of the company’s common stock. This represents an increase from around 133,700 shares held at the end of June.

Ken Griffin

As it has been said earlier, Citadel has recently increased its position in several other companies. Last week, the fund reported raising its stake to Starwood Waypoint Residential Trust (NYSE:SWAY) real estate investment trust to over 2.0 million shares (5.4% of the company) from 313,000 shares held previously. At the end of September, the investor added over 2.7 million shares to its position in Acxiom Corporation (NASDAQ:ACXM), currently holding 5.2% of the company, and it increased its stake in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) to 3.17 million shares from 77,400 shares.

What all these companies have in common is that their stocks dropped significantly since the beginning of the year. Angie’s List Inc (NASDAQ:ANGI) also falls under this category, losing over 55% year-to-date.

Mr. Griffin is a genius investor, who leads one of the largest hedge funds in the world, with over $107 billion in assets under management and an equity portfolio worth $72 billion. Even though Citadel like to keep the data about its performance private, Bloomberg mentioned a couple of weeks ago, that the fund added around 4% in September, when many other hedge funds suffered losses from the main indices losing ground. So far, Citadel’s returns for 2014 amount to around 15%.

In this way, tracking Mr. Griffin’s bullish moves makes a lot of sense for retail investors, especially in the small-cap stocks, such as Angie’s List Inc (NASDAQ:ANGI). Moreover, other prominent investors are also betting on the company. The previous round of 13F filings showed Andy Redleaf‘s Whitebox Advisors raising its stake by 60% on the quarter to 1.09 million shares, while David Shaw’s D. E. Shaw surged its position by 1,500% to 682,700 shares. Moreover, Millennium Management, led by Israel Englander, and Jim Simons‘ Renaissance Technologies initiated stakes in the company during the second quarter and own 449,300 shares and 416,400 shares respectively. However, the holdings amass very small portions of the total equity portfolios values, which is usually the case with small companies.

Insiders are also betting on Angie’s List Inc (NASDAQ:ANGI). Over the last two months, Steven Kapner, a director of the company, has been constantly buying shares, currently holding over 11.6 million shares. However, insiders purchased stock higher than the current price. In addition, several other insiders unloaded stock earlier this year at prices between $9.9 and $12.40 per unit.

With this in mind, on the back of a bullish sentiment from investors and insiders, Angie’s List Inc (NASDAQ:ANGI), a small cap company that is engaged in consumer research related to the home, healthcare and automotive services, is worth further research and worth to be kept on the radars. Analysts also have a positive outlook for the stock, with the average price target topping $10 per share.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!